Cargando…
Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease
BACKGROUND AND PURPOSE: Calcification of heart valves is a frequent pathological finding in chronic kidney disease and in elderly patients. Hydrogen sulfide (H(2)S) may exert anti‐calcific actions. Here we investigated H(2)S as an inhibitor of valvular calcification and to identify its targets in th...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024713/ https://www.ncbi.nlm.nih.gov/pubmed/31017307 http://dx.doi.org/10.1111/bph.14691 |
_version_ | 1783498445320880128 |
---|---|
author | Sikura, Katalin Éva Potor, László Szerafin, Tamás Oros, Melinda Nagy, Péter Méhes, Gábor Hendrik, Zoltán Zarjou, Abolfazl Agarwal, Anupam Posta, Niké Torregrossa, Roberta Whiteman, Matthew Fürtös, Ibolya Balla, György Balla, József |
author_facet | Sikura, Katalin Éva Potor, László Szerafin, Tamás Oros, Melinda Nagy, Péter Méhes, Gábor Hendrik, Zoltán Zarjou, Abolfazl Agarwal, Anupam Posta, Niké Torregrossa, Roberta Whiteman, Matthew Fürtös, Ibolya Balla, György Balla, József |
author_sort | Sikura, Katalin Éva |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Calcification of heart valves is a frequent pathological finding in chronic kidney disease and in elderly patients. Hydrogen sulfide (H(2)S) may exert anti‐calcific actions. Here we investigated H(2)S as an inhibitor of valvular calcification and to identify its targets in the pathogenesis. EXPERIMENTAL APPROACH: Effects of H(2)S on osteoblastic transdifferentiation of valvular interstitial cells (VIC) isolated from samples of human aortic valves were studied using immunohistochemistry and western blots. We also assessed H2S on valvular calcification in apolipoprotein E‐deficient (ApoE(−/−)) mice. KEY RESULTS: In human VIC, H(2)S from donor compounds (NaSH, Na(2)S, GYY4137, AP67, and AP72) inhibited mineralization/osteoblastic transdifferentiation, dose‐dependently in response to phosphate. Accumulation of calcium in the extracellular matrix and expression of osteocalcin and alkaline phosphatase was also inhibited. RUNX2 was not translocated to the nucleus and phosphate uptake was decreased. Pyrophosphate generation was increased via up‐regulating ENPP2 and ANK1. Lowering endogenous production of H(2)S by concomitant silencing of cystathionine γ‐lyase (CSE) and cystathionine β‐synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). In contrast, tissue H(2)S generation was lower in AS valves compared to AI valves. Valvular calcification in ApoE(−/−) mice on a high‐fat diet was inhibited by H(2)S. CONCLUSIONS AND IMPLICATIONS: The endogenous CSE‐CBS/H(2)S system exerts anti‐calcification effects in heart valves providing a novel therapeutic approach to prevent hardening of valves. LINKED ARTICLES: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc |
format | Online Article Text |
id | pubmed-7024713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70247132020-02-21 Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease Sikura, Katalin Éva Potor, László Szerafin, Tamás Oros, Melinda Nagy, Péter Méhes, Gábor Hendrik, Zoltán Zarjou, Abolfazl Agarwal, Anupam Posta, Niké Torregrossa, Roberta Whiteman, Matthew Fürtös, Ibolya Balla, György Balla, József Br J Pharmacol Themed Section: Research Papers BACKGROUND AND PURPOSE: Calcification of heart valves is a frequent pathological finding in chronic kidney disease and in elderly patients. Hydrogen sulfide (H(2)S) may exert anti‐calcific actions. Here we investigated H(2)S as an inhibitor of valvular calcification and to identify its targets in the pathogenesis. EXPERIMENTAL APPROACH: Effects of H(2)S on osteoblastic transdifferentiation of valvular interstitial cells (VIC) isolated from samples of human aortic valves were studied using immunohistochemistry and western blots. We also assessed H2S on valvular calcification in apolipoprotein E‐deficient (ApoE(−/−)) mice. KEY RESULTS: In human VIC, H(2)S from donor compounds (NaSH, Na(2)S, GYY4137, AP67, and AP72) inhibited mineralization/osteoblastic transdifferentiation, dose‐dependently in response to phosphate. Accumulation of calcium in the extracellular matrix and expression of osteocalcin and alkaline phosphatase was also inhibited. RUNX2 was not translocated to the nucleus and phosphate uptake was decreased. Pyrophosphate generation was increased via up‐regulating ENPP2 and ANK1. Lowering endogenous production of H(2)S by concomitant silencing of cystathionine γ‐lyase (CSE) and cystathionine β‐synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). In contrast, tissue H(2)S generation was lower in AS valves compared to AI valves. Valvular calcification in ApoE(−/−) mice on a high‐fat diet was inhibited by H(2)S. CONCLUSIONS AND IMPLICATIONS: The endogenous CSE‐CBS/H(2)S system exerts anti‐calcification effects in heart valves providing a novel therapeutic approach to prevent hardening of valves. LINKED ARTICLES: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc John Wiley and Sons Inc. 2019-04-24 2020-02 /pmc/articles/PMC7024713/ /pubmed/31017307 http://dx.doi.org/10.1111/bph.14691 Text en © 2019 University of Debrecen Faculty of medicine. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Themed Section: Research Papers Sikura, Katalin Éva Potor, László Szerafin, Tamás Oros, Melinda Nagy, Péter Méhes, Gábor Hendrik, Zoltán Zarjou, Abolfazl Agarwal, Anupam Posta, Niké Torregrossa, Roberta Whiteman, Matthew Fürtös, Ibolya Balla, György Balla, József Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title_full | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title_fullStr | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title_full_unstemmed | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title_short | Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
title_sort | hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease |
topic | Themed Section: Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024713/ https://www.ncbi.nlm.nih.gov/pubmed/31017307 http://dx.doi.org/10.1111/bph.14691 |
work_keys_str_mv | AT sikurakatalineva hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT potorlaszlo hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT szerafintamas hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT orosmelinda hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT nagypeter hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT mehesgabor hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT hendrikzoltan hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT zarjouabolfazl hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT agarwalanupam hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT postanike hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT torregrossaroberta hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT whitemanmatthew hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT furtosibolya hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT ballagyorgy hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease AT ballajozsef hydrogensulfideinhibitscalcificationofheartvalvesimplicationsforcalcificaorticvalvedisease |